Clinical Trial Update: The Iguratimod Effect on Lupus Nephritis (IGeLU) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating iguratimod for lupus nephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Iguratimod (iguratimod)

Snippet

Sponsor: RenJi Hospital | Conditions: Lupus Nephritis | Phase 2 | Status: UNKNOWN